SequelSEC

ZIMMER BIOMET HOLDINGS, INC. ZBH

Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0001136869 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$8.51B
Fiscal year ended 2026-06-30
Operating income
$1.21B
Fiscal year ended 2026-06-30
Free cash flow
$1.52B
Fiscal year ended 2026-06-30

ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported revenue of $8.51B and net income of $806.60M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from ZIMMER BIOMET HOLDINGS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Income

ZIMMER BIOMET HOLDINGS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$8.51B
Cost of revenue$2.56B
Gross profit$5.95B
Operating income$1.21B
Net income$806.60M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$933.60M
Income tax expense$126.60M
Diluted EPSUnavailable
Selling, general & administrative$3.43B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

ZIMMER BIOMET HOLDINGS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$410.00M
Total assets$22.80B
Current assets$5.10B
Total liabilities$10.17B
Current liabilities$3.01B
Total equity incl. NCI$12.63B
Temporary (mezzanine) equityUnavailable
Inventory$2.27B
Accounts receivable$1.77B
Goodwill$9.92B
Long-term debt$6.28B
Accounts payable$352.40M

Cash flow

ZIMMER BIOMET HOLDINGS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$1.74B
Capital expenditures$220.30M
Investing cash flow-$835.10M
Financing cash flow-$1.05B
Net change in cash-$146.90M
Stock-based compensation$98.20M
Common dividends paid$188.40M
Common share repurchases$750.80M
Depreciation & amortization$1.11B

Derived

ZIMMER BIOMET HOLDINGS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$1.52B
Gross margin69.9%
Operating margin14.2%
FCF margin17.9%
SBC / revenue1.2%
Current ratio1.69x
Revenue YoY growth8.6%
Net margin9.5%
R&D / revenueUnavailable
CapEx / revenue2.6%
Long-term debt / equity0.50x
Effective tax rate13.6%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ZBH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-02-20View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-05View SEC filing

Companies in the same industry

ALGN APT AVR BBLG CDRE COCH ENOV ESTA EW FEED INGN ISRG

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.